TD Cowen Starts Alto Neuroscience (ANRO) at Outperform, 'Redefining Psychiatry With Precision'
Tweet Send to a Friend
TD Cowen analyst Ritu Baral initiates coverage on Alto Neuroscience (NYSE: ANRO) with a Outperform rating.The analyst comments "We are ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
